Dec 10, 2019
Invitae Announces Program with BioMarin to Expand Access to Genetic Testing for Skeletal Dysplasias
Dec 03, 2019
Censa Pharmaceuticals Announces CNSA-001 Met Primary and Secondary Endpoints in Phase 2 Trial in Patients with PKU
Nov 21, 2019
BioMarin Submits Marketing Authorization Application to European Medicines Agency for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A
Nov 14, 2019
Poised for Significant Growth and Profitability, BioMarin Shares Company Highlights During R&D Day on November 14th in New York
Nov 14, 2019
BioMarin Announces Cumulative Additional Height Gain of 9.0 cm over 54 months versus Natural History in Children with Achondroplasia Treated with Vosoritide in Phase 2 Study
Nov 12, 2019
BioMarin to Participate in Jefferies London Healthcare Conference on November 21, 2019
Nov 06, 2019
BioMarin to Highlight Innovative Development Pipeline at R&D Day on November 14th
Oct 23, 2019
BioMarin Announces Third Quarter 2019 Financial Results
Oct 23, 2019
Allievex Completes Series A Financing Led by Pappas Capital and Novo Holdings
Oct 09, 2019
BioMarin to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, October 23 at 4:30pm ET
Oct 07, 2019
BioMarin Promotes Lon Cardon, Ph.D. to Chief Scientific Strategy Officer
Oct 01, 2019
BioMarin to Participate in Jefferies Gene Therapy/Editing Summit on October 8, 2019 in New York
Sep 26, 2019
BioMarin, Pioneer in Phenylketonuria (PKU) Therapies, Submits Clinical Trial Application (CTA) in U.K. for Investigational Gene Therapy for PKU
Sep 12, 2019
Aristea Therapeutics Announces Formation of Scientific Advisory Board
Sep 09, 2019
BioMarin to Participate in Morgan Stanley 17th Annual Global Healthcare Conference on September 10, 2019 in New York
Aug 28, 2019
BioMarin to Participate in Morgan Stanley 17th Annual Global Healthcare Conference on September 10, 2019 in New York
Aug 06, 2019
Emil Kakkis joins Nonprofit Biotech Odylia Therapeutics Board of Directors
Aug 01, 2019
BioMarin Announces Second Quarter 2019 Financial Results
Jul 16, 2019
BioMarin to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 1 at 4:30pm ET
Jul 09, 2019
BioMarin Appoints Pharmaceutical Veteran and Former J & J Executive, Liz McKee Anderson, to Board of Directors